Tricuspid Valve Repair Market Will Generate Booming Growth Opportunities to 2031

The global Tricuspid Valve Repair Market size is expected to witness a CAGR of 6% by 2031. The growth of the market can be attributed to the introduction of technologically advanced equipment in the healthcare sector, the rise in per capita healthcare spending, and the increasing percentage of cardiovascular diseases all over the world. Another major reason that pushes the industry's growth is the rising adoption of minimally invasive surgeries, such as annuloplasty. As a result, manufacturers are focusing on developing technologically advanced annuloplasty rings. During tricuspid valve repair procedures, placement of annuloplasty ring results in improved long-term outcomes and reduces the reoccurrence of tricuspid regurgitation.

Download Sample PDF: https://meditechinsights.com/tricuspid-valve-repair-market/request-sample/

The tricuspid valve is one of four critical valves that regulate blood flow in the heart. Located on the right side, it sits between the right atrium (upper chamber) and the right ventricle (lower chamber), ensuring blood flows in the correct direction. The valve has three flaps, or leaflets, that open and close with each heartbeat, allowing blood to pass from the atrium to the ventricle. However, certain conditions can affect its function, leading to what are known as tricuspid valve diseases. The main types include:

• Tricuspid Regurgitation: The valve doesn’t close tightly enough, causing blood to leak backward into the atrium.
• Tricuspid Stenosis: The valve leaflets become stiff and thickened, limiting blood flow.

Tricuspid valve replacement and repair are key procedures used to treat these conditions. When possible, repair is preferred over replacement with a prosthetic valve. Valve repair typically involves modifying the valve’s tissue or its surrounding structures. A common part of the repair procedure is the implantation of an annuloplasty ring or band. This cloth-covered device is placed around the valve’s annulus (the ring-like structure that holds the valve in place), helping to support the valve and bring its leaflets closer together, potentially reducing leaks. This procedure can improve symptoms and enhance survival rates for patients with tricuspid regurgitation or stenosis.

Tricuspid Valve Repair Market Analysis

• Tricuspid valve repair procedures, which restore the function of the heart’s tricuspid valve without the need for replacement, are becoming increasingly vital in the management of valvular heart diseases. These procedures are preferred for their ability to preserve native valve anatomy, reduce complications, and improve long-term patient outcomes, especially in both aging populations and individuals with functional tricuspid regurgitation
• The growing demand for tricuspid valve repair is primarily fueled by the increasing prevalence of cardiovascular diseases, rising awareness about early intervention, and advancements in minimally invasive and transcatheter technologies, which offer safer alternatives to open-heart surgery
• North America dominated the tricuspid valve repair market with the largest revenue share in 2024, driven by the region’s strong healthcare infrastructure, early adoption of innovative cardiac therapies, high prevalence of cardiac disorders, and the presence of leading device manufacturers. The U.S. particularly experienced significant uptake in tricuspid valve repair procedures, supported by favorable reimbursement policies and growing clinical evidence supporting transcatheter repair techniques
• Asia-Pacific is projected to be the fastest-growing region in the tricuspid valve repair market during the forecast period. Growth is supported by increasing healthcare investments, rising awareness about structural heart disease, expanding geriatric population, and the introduction of advanced cardiac intervention centers across emerging economies such as China and India
• The tricuspid valve regurgitation segment dominated the tricuspid valve repair market with a market revenue share in 2024, primarily due to its higher prevalence globally, especially among the elderly population and patients with left-sided heart disease or pulmonary hypertension. The availability of transcatheter and surgical repair solutions has further strengthened the market for regurgitation management

Download Sample PDF: https://meditechinsights.com/tricuspid-valve-repair-market/request-sample/

Tricuspid Valve Repair Market: Competitive Landscape

The top market players in the global tricuspid valve repair market include Edwards Lifesciences Corp., Abbott, Medtronics, Corcym, Labcor, Valtech Cardio Ltd., Sorin S.p.A., CroiValve, FOLDAX, Cardia Implant LLC, LivaNova PLC, Cyberonics Inc., Boston Scientific Corporation, Micro Interventional Devices Inc., 4Tech Inc., among others.

Rising Demand for Tricuspid Valve Repair Due to Advances in Treating Tricuspid Regurgitation

Tricuspid regurgitation (TR) is the most common reason for tricuspid valve repair. In the U.S., an estimated 1.6 million people suffer from moderate to severe TR, while only a few thousand undergo the procedure each year. This patient group is typically elderly, experiencing symptoms like fatigue, limited exercise tolerance, swollen legs, and abdominal bloating. Medical treatment, including high-dose diuretics, offers limited relief, making surgery the best long-term solution. However, despite the inclusion of tricuspid valve surgery in clinical guidelines, its treatment rate is lower than for other valve diseases, and the mortality rate is higher. Due to significant comorbidities, fewer than 1% of patients are eligible for surgery. Most are left with only medical management to temporarily reduce symptoms.

As a result, there is increasing interest in less invasive procedures compared to traditional open-heart surgery. For example:

• October 2023: Edwards Lifesciences Corporation announced that its EVOQUE tricuspid valve replacement system had received CE Mark approval for the transcatheter treatment of eligible patients with tricuspid regurgitation.
• April 2021: Abbott received CE Mark approval for its next-generation TriClip Transcatheter Tricuspid Valve Repair System, a first-of-its-kind minimally invasive device available in Europe for treating tricuspid regurgitation.

Browse Report: https://meditechinsights.com/tricuspid-valve-repair-market/

Global Tricuspid Valve Repair Market Segmentation

This report by Medi-Tech Insights provides the size of the global tricuspid valve repair market at the regional- and country-level from 2024 to 2031. The report further segments the market based on indication and end user.

• Market Size & Forecast (2024-2031), By Indication, USD Billion
  • Tricuspid Valve Regurgitation
  • Tricuspid Valve Stenosis
• Market Size & Forecast (2024-2031), By End User, USD Billion
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Cardiac Catheterization Laboratories
  • Others
• Market Size & Forecast (2024-2031), By Region, USD Billion
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Related Report:

Pain Management Devices Market   https://www.pharmiweb.com/press-release/2026-05-12/pain-management-devices-market-emerging-as-a-high-growth-healthcare-investment-space-through-2030

Anti-snoring Devices Market https://www.pharmiweb.com/press-release/2026-05-12/anti-snoring-devices-market-revenue-modeling-and-strategic-forecast-2026-to-2031

Hospital Information Systems Market          https://www.pharmiweb.com/press-release/2026-05-14/hospital-information-systems-market-size-is-expected-to-witness-substantial-growth-at-a-significant-cagr-by-2031

Bunion Surgery Market          https://www.pharmiweb.com/press-release/2026-05-14/bunion-surgery-market-growth-outlook-segmentation-industry-trends-2026-2031

About Medi-Tech Insights;

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com